Han‐Mo Yang

1.7k total citations
33 papers, 583 citations indexed

About

Han‐Mo Yang is a scholar working on Cardiology and Cardiovascular Medicine, Sociology and Political Science and Health. According to data from OpenAlex, Han‐Mo Yang has authored 33 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 6 papers in Sociology and Political Science and 5 papers in Health. Recurrent topics in Han‐Mo Yang's work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Intergenerational Family Dynamics and Caregiving (6 papers) and Health disparities and outcomes (5 papers). Han‐Mo Yang is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Intergenerational Family Dynamics and Caregiving (6 papers) and Health disparities and outcomes (5 papers). Han‐Mo Yang collaborates with scholars based in South Korea, China and United States. Han‐Mo Yang's co-authors include Zhenjie Wang, Hae‐Young Lee, Hyun‐Jae Kang, Hyo‐Soo Kim, Kyung Woo Park, Bon‐Kwon Koo, Hyun‐Jai Cho, Byung‐Hee Oh, Il‐Young Oh and Do‐Yoon Kang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Han‐Mo Yang

29 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han‐Mo Yang South Korea 13 321 105 82 78 57 33 583
Jean-Michel Gaspoz Switzerland 10 330 1.0× 150 1.4× 84 1.0× 78 1.0× 19 0.3× 11 634
R. Akehurst United Kingdom 17 283 0.9× 222 2.1× 90 1.1× 78 1.0× 17 0.3× 34 1.0k
Seo Hyon Baik United States 15 305 1.0× 57 0.5× 111 1.4× 28 0.4× 13 0.2× 33 783
Catherine Kreatsoulas Canada 11 240 0.7× 119 1.1× 164 2.0× 57 0.7× 81 1.4× 31 643
Joseph Salami United States 14 290 0.9× 254 2.4× 170 2.1× 60 0.8× 81 1.4× 36 911
Luisa C Brant Brazil 11 273 0.9× 47 0.4× 72 0.9× 38 0.5× 27 0.5× 22 486
Soneil Guptha India 16 796 2.5× 111 1.1× 76 0.9× 313 4.0× 53 0.9× 32 1.2k
Sophie H. Bots Netherlands 12 399 1.2× 73 0.7× 71 0.9× 84 1.1× 70 1.2× 23 770
Tamer Yahya United States 15 170 0.5× 63 0.6× 140 1.7× 68 0.9× 128 2.2× 24 626
Felix Eduardo R. Punzalan Philippines 13 351 1.1× 162 1.5× 29 0.4× 154 2.0× 19 0.3× 66 770

Countries citing papers authored by Han‐Mo Yang

Since Specialization
Citations

This map shows the geographic impact of Han‐Mo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Mo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Mo Yang more than expected).

Fields of papers citing papers by Han‐Mo Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Mo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Mo Yang. The network helps show where Han‐Mo Yang may publish in the future.

Co-authorship network of co-authors of Han‐Mo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Mo Yang. A scholar is included among the top collaborators of Han‐Mo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Mo Yang. Han‐Mo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Han‐Mo, et al.. (2025). In vitro interactions of berbamine hydrochloride and azoles against Aspergillus fumigatus. Microbiology Spectrum. 13(5). e0318424–e0318424. 1 indexed citations
2.
Gruber, Jonathan, Meng‐Yun Lin, Han‐Mo Yang, & Junjian Yi. (2025). China’s Social Health Insurance in the Era of Rapid Population Aging. JAMA Health Forum. 6(4). e251105–e251105. 2 indexed citations
3.
Yip, Winnie, Hongqiao Fu, Weiyan Jian, et al.. (2023). Universal health coverage in China part 2: addressing challenges and recommendations. The Lancet Public Health. 8(12). e1035–e1042. 22 indexed citations
5.
Yang, Han‐Mo, Jooeun Lee, Ju‐Young Kim, et al.. (2023). Identification of cell-biologic mechanisms of coronary artery spasm and its ex vivo diagnosis using peripheral blood-derived iPSCs. Biomaterials Research. 27(1). 16–16. 3 indexed citations
6.
Yip, Winnie, Hongqiao Fu, Weiyan Jian, et al.. (2023). Universal health coverage in China part 1: progress and gaps. The Lancet Public Health. 8(12). e1025–e1034. 32 indexed citations
7.
Yang, Han‐Mo, et al.. (2023). Third-child fertility intention and its socioeconomic factors among women aged 20–34 years in China. BMC Public Health. 23(1). 821–821. 21 indexed citations
8.
Kang, Jeehoon, Jung‐Kyu Han, Han‐Mo Yang, et al.. (2023). Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry. BMC Cardiovascular Disorders. 23(1). 6–6. 2 indexed citations
9.
Ahmed, Tarek, You‐Jeong Ki, Heba M. El-Naggar, et al.. (2022). Impact of Systemic Inflammatory Response Syndrome on Clinical, Echocardiographic, and Computed Tomographic Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation. Frontiers in Cardiovascular Medicine. 8. 746774–746774. 5 indexed citations
10.
Du, Xiaojing, et al.. (2022). Prevalence of Disability among the Chinese Older Population: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 19(3). 1656–1656. 33 indexed citations
12.
Liu, Gordon G., et al.. (2020). Does Ownership Matter for Medical System Performance? Evidence From a Natural Experiment in Suqian, China. INQUIRY The Journal of Health Care Organization Provision and Financing. 57. 1143497170–1143497170. 3 indexed citations
13.
Wang, Zhenjie, et al.. (2020). Life negative events and depressive symptoms: the China longitudinal ageing social survey. BMC Public Health. 20(1). 968–968. 18 indexed citations
15.
Kang, Jeehoon, Jung‐Kyu Han, Youngkeun Ahn, et al.. (2018). Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study. Thrombosis and Haemostasis. 118(3). 591–600. 42 indexed citations
16.
Lee, Sang Eun, Hyun‐Jai Cho, Hae‐Young Lee, et al.. (2014). A Multicentre Cohort Study of Acute Heart Failure Syndromes in Korea: Rationale, Design, and Interim Observations of the Korean Acute Heart Failure (KorAHF) Registry. European Journal of Heart Failure. 16(6). 700–708. 122 indexed citations
17.
Yang, Han‐Mo, Sooryeonhwa Jin, Byung‐Hee Oh, Young-Bae Park, & Hyo‐Soo Kim. (2014). SILDENAFIL INHIBITS PLATELET AGGREGATION AND REDUCES NEOINTIMAL HYPERPLASIA AFTER VASCULAR INJURY. Journal of the American College of Cardiology. 63(12). A2120–A2120.
18.
Park, Jin Joo, Kyung Woo Park, Jeehoon Kang, et al.. (2012). Genetic determinants of clopidogrel responsiveness in Koreans treated with drug-eluting stents. International Journal of Cardiology. 163(1). 79–86. 26 indexed citations
19.
Park, Kyung Woo, Jeehoon Kang, Jin Joo Park, et al.. (2012). Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention. Heart. 98(18). 1366–1372. 24 indexed citations
20.
Park, Jun‐Bean, Do‐Yoon Kang, Han‐Mo Yang, et al.. (2012). Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent. European Heart Journal. 34(12). 920–931. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026